SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-21-000006
Filing Date
2021-10-04
Accepted
2021-10-04 16:01:51
Documents
14
Period of Report
2021-10-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea148359-8k_augmedix.htm   iXBRL 8-K 24024
2 AUGMEDIX, INC. PRESS RELEASE, ANNOUNCING PRELIMINARY THIRD QUARTER 2021 FINANCIA ea148359ex99-1_augmedix.htm EX-99.1 21129
6 GRAPHIC ex99-1_001.jpg GRAPHIC 10776
  Complete submission text file 0001013762-21-000006.txt   234162

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE augx-20211004.xsd EX-101.SCH 3025
4 XBRL LABEL FILE augx-20211004_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE augx-20211004_pre.xml EX-101.PRE 22359
7 EXTRACTED XBRL INSTANCE DOCUMENT ea148359-8k_augmedix_htm.xml XML 3389
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISC CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

IRS No.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56036 | Film No.: 211302624
SIC: 7389 Services-Business Services, NEC